\-\ Texto\\:\\ \ \(0\)\
\-\ proptosis\\ on\\ left\\.\ \(0\)\
\-\ none\\ to\\ date\\.\\ \\ clinical\\ followup\\,\\ unless\\ symptomatic\\.\ \(0\)\
\-\ enlargement\\ of\\ cisternal\\ and\\ orbital\\ portion\\ of\\ left\\ optic\\ nerve\\.\\ \\ no\\ pathologic\\ enhancement\\.\ \(0\)\
\-\ left\\ optic\\ nerve\\ glioma\\,\\ neurofibromatosis\\ 1\\ \\(nf1\\)\ \(0\)\
\-\ \\â\\€\\¢\\ meningioma\ \(7\)\
\-\ \\â\\€\\¢\\ glioma\ \(2\)\
\-\ \\â\\€\\¢\\ neuritis\ \(0\)\
\-\ two\\ year\\ old\\ girl\\ presented\\ at\\ age\\ 11\\ months\\ with\\ left\\ sided\\ proptosis\\.\ \(0\)\
\-\ this\\ patient\\ was\\ clinically\\ diagnosed\\ with\\ neurofibromatosis\\ type\\ 1\\ \\(nf1\\)\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ nf1\\:\\ 0\\.16851563605381076\ \(0\)\
\-\ proptosis\\:\\ 0\\.13443569453892812\ \(0\)\
\-\ neurofibromatosis\\:\\ 0\\.13299081300688445\ \(0\)\
\-\ optic\\:\\ 0\\.11142833858041763\ \(0\)\
\-\ glioma\\:\\ 0\\.10852602235793214\ \(0\)\
\-\ cisternal\\:\\ 0\\.09321540629056731\ \(0\)\
\-\ nerve\\:\\ 0\\.08673087680245933\ \(0\)\
\-\ neuritis\\:\\ 0\\.07625804284935694\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.06621187401109385\ \(0\)\
\-\ unless\\:\\ 0\\.06515300960478976\ \(0\)\
\-\ date\\:\\ 0\\.06047506826644307\ \(0\)\
\-\ followup\\:\\ 0\\.057455210923549334\ \(0\)\
\-\ 1\\:\\ 0\\.05727679909745653\ \(0\)\
\-\ orbital\\:\\ 0\\.05708935900237665\ \(0\)\
\-\ 11\\:\\ 0\\.05507385416236717\ \(0\)\
\-\ left\\:\\ 0\\.05386508559284027\ \(0\)\
\-\ clinically\\:\\ 0\\.05276921439079249\ \(0\)\
\-\ pathologic\\:\\ 0\\.052680909982150304\ \(0\)\
\-\ symptomatic\\:\\ 0\\.047816667953439605\ \(0\)\
\-\ enlargement\\:\\ 0\\.04775448459838163\ \(0\)\
\-\ meningioma\\:\\ 0\\.0462829484007757\ \(0\)\
\-\ sided\\:\\ 0\\.044500374833051345\ \(0\)\
\-\ diagnosed\\:\\ 0\\.04425626981401416\ \(0\)\
\-\ portion\\:\\ 0\\.04359445982195897\ \(0\)\
\-\ girl\\:\\ 0\\.04231517508436335\ \(0\)\
\-\ type\\:\\ 0\\.04057217223023817\ \(0\)\
\-\ clinical\\:\\ 0\\.03703253239529584\ \(0\)\
\-\ age\\:\\ 0\\.03663253979639868\ \(0\)\
\-\ two\\:\\ 0\\.03446945405092966\ \(0\)\
\-\ months\\:\\ 0\\.03287241260126855\ \(0\)\
\-\ presented\\:\\ 0\\.03280785401440013\ \(0\)\
\-\ enhancement\\:\\ 0\\.03226040515666248\ \(0\)\
\-\ none\\:\\ 0\\.02985520432264798\ \(0\)\
\-\ \\(\\:\\ 0\\.020348217640672128\ \(0\)\
\-\ \\)\\:\\ 0\\.02009965329896634\ \(0\)\
\-\ at\\:\\ 0\\.016306523279318776\ \(0\)\
\-\ was\\:\\ 0\\.013919401721319533\ \(0\)\
\-\ this\\:\\ 0\\.013537143849494832\ \(0\)\
\-\ year\\:\\ 0\\.013466271398210067\ \(0\)\
\-\ old\\:\\ 0\\.01232302249101767\ \(0\)\
\-\ no\\:\\ 0\\.01211893170005355\ \(0\)\
\-\ patient\\:\\ 0\\.012064675083329408\ \(0\)\
\-\ on\\:\\ 0\\.010195648061484902\ \(0\)\
\-\ \\,\\:\\ 0\\.007625635648374292\ \(0\)\
\-\ to\\:\\ 0\\.00601504378088713\ \(0\)\
\-\ with\\:\\ 0\\.0032958922842222464\ \(0\)\
\-\ of\\:\\ 0\\.003281797205577139\ \(0\)\
\-\ \\.\\:\\ 0\\.00299996079695884\ \(0\)\
\-\ and\\:\\ 0\\.002535338108904485\ \(0\)\
